Valuation: Bio-Rad Laboratories, Inc.

Market Cap 8.11B 7.11B 6.6B 6.06B 11.43B 783B 11.59B 78.61B 30.77B 383B 30.45B 29.8B 1,323B P/E 2026 *
36.3x
P/E 2027 * 35.5x
Enterprise Value 7.36B 6.45B 5.99B 5.5B 10.37B 711B 10.52B 71.36B 27.93B 348B 27.64B 27.05B 1,201B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 2.71x
Free-Float
60.28%
Yield 2026 *
-
Yield 2027 * -
1 day+1.41%
1 week+3.46%
Current month+4.21%
1 month+8.84%
3 months+1.72%
6 months+0.24%
Current year+0.98%
1 week 285.39
Extreme 285.39
307.49
1 month 270
Extreme 270
307.49
Current year 236.73
Extreme 236.73
328.56
1 year 236.73
Extreme 236.73
343.12
3 years 211.43
Extreme 211.43
431.79
5 years 211.43
Extreme 211.43
832.7
10 years 142.06
Extreme 142.06
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap.
5/11/26 Sell

Executive/Senior Manager

-550 0.0025%
4/24/26 Fiscal year

General Counsel

449 0.0020%
4/24/26 Fiscal year

Chief Financial Officer

2,576 0.0117%
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%+3.46%+24.64%-26.61% 8.11B
+0.90%+12.66%-20.01%-12.26% 174B
-0.56%+1.76%-10.65%-7.74% 105B
-0.82%+1.35%+2.60%+57.00% 58.97B
-1.59%-2.05%+36.71%+59.47% 52.24B
-0.44%-1.11%-15.51%-45.29% 42.39B
-4.89%-5.73% - - 33.05B
-4.44%-1.79%-16.08%-44.07% 28.84B
-0.23%-0.16%+63.73%-4.69% 25.38B
-0.56%-0.42%-5.87%-9.30% 20.64B
Average -1.19%+2.28%+6.62%-3.72% 54.86B
Weighted average by Cap. -0.83%+4.90%-3.78%-0.38%

Financials

2026 *2027 *
Net sales 2.57B 2.25B 2.09B 1.92B 3.62B 248B 3.67B 24.88B 9.74B 121B 9.64B 9.43B 419B 2.63B 2.31B 2.14B 1.97B 3.71B 254B 3.77B 25.53B 9.99B 124B 9.89B 9.68B 430B
Net income 225M 197M 183M 168M 317M 21.7B 321M 2.18B 853M 10.62B 844M 826M 36.67B 230M 201M 187M 172M 324M 22.17B 328M 2.23B 871M 10.85B 862M 844M 37.47B
Net Debt -749M -656M -609M -560M -1.05B -72.28B -1.07B -7.26B -2.84B -35.37B -2.81B -2.75B -122B -965M -846M -785M -722M -1.36B -93.16B -1.38B -9.36B -3.66B -45.58B -3.62B -3.55B -157B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-07-22 US$305.96 +1.41% 274,877
26-07-21 US$301.70 -0.07% 302,880
26-07-20 US$301.90 -0.81% 454,218
26-07-17 US$304.36 +1.12% 287,199
26-07-16 US$300.98 +1.78% 237,474
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
301.70USD
Average target price
297.00USD
Spread / Average Target
-1.56%

Quarterly revenue - Rate of surprise